Onsite Women’s Health Advances Preventive Care with 
AI-Enabled Mammography and Cardiac Risk Insight

Onsite Women’s Health Advances Preventive Care withAI-Enabled Mammography and Cardiac Risk Insight

NASHVILLE, Tenn., Feb. 3, 2026 – Onsite Women’s Health, the nation’s largest provider of in-office breast health and imaging services, today announced the launch of Mammo with heart, an AI-enabled clinical program designed to enhance preventive care for women by identifying the presence of breast arterial calcifications (BAC) — a marker associated with cardiovascular disease — during routine screening mammograms. The program is powered by FDA-cleared artificial intelligence technology from CureMetrix® and is currently available at Intermountain Medical Clinic, an Onsite-affiliated practice, with plans to expand to additional markets this year.

The launch coincides with American Heart Month, underscoring the growing importance of cardiovascular awareness in women’s preventive care. Cardiovascular disease remains the leading cause of death for women, according to the American Heart Association, yet risk often goes undetected until later stages. Mammo with heart offers an opportunity to identify additional cardiovascular insight during a routine exam many women are already receiving.

By combining CureMetrix’s cmAngio® software with Onsite’s comprehensive 3D screening mammography service, Mammo with heart enables a standard screening mammogram to deliver additional insights into a woman’s overall health — enhancing the impact of an exam she is already receiving. This innovation allows a mammogram to serve as a “two-for-one” exam, without requiring additional procedures, appointments or radiation exposure. 

“We’re thrilled to partner with CureMetrix to explore new ways AI can expand the value of traditional mammography, revealing important insights that may have gone unnoticed in the past,” said Jillian Wright, chief executive officer at Onsite Women’s Health. “As the partner of choice for in-office breast health and imaging services, we believe it’s our responsibility to extract the fullest potential from every mammogram — not only to detect cancer, but to surface broader insights into women’s health, including cardiovascular risk. This partnership brings us one step closer to using today’s mammogram to inform tomorrow’s care.”

Among women who undergo screening mammograms, breast arterial calcifications are present in approximately 12% to 42.5% of cases (Source 1). However, fewer than 5% of these incidental findings are typically reported (Source 2). Research shows that both patients and referring physicians increasingly want to be informed when these findings are present (Source 3). 

Onsite Women’s Health delivers comprehensive, in-office breast health and imaging services across more than 175 practices in 28 states and is projected to perform more than 600,000 breast exams in 2026. The addition of Mammo with heart further advances Onsite’s objective to increase early detection, improve patient compliance and elevate women’s health outcomes nationwide.

Source 1
CSBI Position Statement csbi.ca/canadian-society-of-breast-imaging-position-statement-on-breast-arterial-calcification-reporting-on-mammography/

Source 2
Internal CureMetrix analysis of 346,000 mammograms collected from 2008-2018

Source 3
Breast Arterial Calcification in the Mammogram Report: The Patient Perspective
AJR. 2019;212:209-214. doi:10.2214/AJR.18.20171

About Onsite Women’s Health
In partnership with forward-thinking providers across the country, Onsite Women’s Health offers comprehensive in-office breast health and imaging services – anchored by a strong 3D screening mammography platform complete with AI for cancer detection.Committed to saving more women’s lives through earlier diagnosis, Onsite is driving measurable improvements in breast cancer screening compliance and detection rates by expanding convenient access to mammography, working with breast-specialized radiologists and utilizing the most advanced equipment and AI-powered technology available. Onsite’s model enhances patient satisfaction, strengthens breast health services and creates new revenue opportunities for practice partners. Since its founding in 2008, Onsite has performed more than two million exams across 28 states.

MEDIA CONTACT:

Julie Plummer  
615-268-2465